Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists

Cancer

Volumn 118, Issue 18, 2012, Pages 4404-4411

  Hassan, Cesare ^a   Rex, Douglas K ^b   Zullo, Angelo ^a   Cooper, Gregory S ^c  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

colonoscopy; colorectal cancer screening; cost effectiveness; endoscopist; interval cancer; specialist

Indexed keywords

ARTICLE; CANCER PREVENTION; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIST; GASTROENTEROLOGIST; HIDDEN MARKOV MODEL; PHYSICIAN; PRIORITY JOURNAL; SIMULATION; UNITED STATES;

COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; MARKOV CHAINS; MASS SCREENING;

EID: 84865969350     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27664     Document Type: Article

References (35)

1. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010; 116: 544-573.
2. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012; 366: 687-696.
3. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol. 2009; 104: 739-750.
4. Kahi CJ, Imperiale TF, Juliar BE, Rex DK,. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009; 7: 770-775.
5. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009; 150: 1-8.
6. Singh H, Turner D, Xue L, et al. Risk of developing colorectal cancer following a negative colonoscopy examination. JAMA. 2006; 295: 2366-2373.
7. Singh H, Nugent Z, Demers AA, et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology. 2010; 139: 1128-1137.
8. Rex DK, Bond JH, Winawer S, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2002; 97: 1296-1308.
9. Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM,. Prevalence and predictors of interval colorectal cancers in Medicare beneficiaries [published online ahead of print October 11, 2011]. Cancer. 2011.
10. Singh H, Nugent Z, Demers AA, Bernstein CN,. Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol. 2010; 105: 2588-2596.
11. Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L,. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011; 140: 65-72.
12. Hassan C, Rex DK, Cooper GS, et al. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis [published online ahead of print October 13, 2011]. Gut. 2011.
13. Kaminski MF, Regula JR, Kraszewska E, et al. Quality indicators for Colonoscopy and the Risk of Interval Cancer. N Engl J Med. 2010; 362: 1795-1803.
14. American Board of Internal Medicine. Available at: http://www.abim. org/pdf/data-candidates-certified/all-candidates.pdf [Accessed October 1, 2011].
15. DiSario JA, Foutch PG, Mai HD, Pardy K, Manne RK,. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol. 1991; 86: 941-945.
16. Loeve F, Boer R, Zauber AG, et al. National Polyp Study data: evidence for regression of adenomas. Int J Cancer. 2004; 111: 633-639.
17. Hofstad B, Vatn M, Larsen S, et al. Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of 3 years. Gut. 1996; 39: 449-456.
18. Surveillance, Epidemiology, and End Results (SEER) Program; National Cancer Institute. Fast Stats. Available at: http://seer.cancer.gov/faststats/. Accessed January 15, 2011.
19. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997; 112: 24-28.
20. Levin TR, Zhao W, Conell C, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006; 145: 880-886.
21. Centers for Medicare and Medicaid Services. Physician fee schedule look-up. Available at: http://www.cms.hhs.gov/pfslookup. Accessed September 15, 2008.
22. US Department of Labor. Bureau of Labor Statistics. Consumer price index for all urban consumers (CPI-U), US city average, medical care. Available at: www.bls.gov/cpi/home.htm. Accessed February 14, 2010.
23. Tengs TO, Wallace A,. One thousand health-related quality-of-life estimates. Med Care. 2000; 38: 583-637.
24. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening among adults aged 50-75 years-United States, 2008. MMWR Morb Mortal Wkly Rep. 2010; 59: 808-812.
25. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010; 375: 1624-1633.
26. Xirasagar S, Hurley TG, Burch JB, Mansaray A, Hebert JR,. Colonoscopy screening rates among patients of colonoscopy-trained African American primary care physicians. Cancer. 2011; 117: 5151-5160.
27. Rex DK, Rahmani EY, Haseman JH, et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology. 1997; 112: 17-23.
28. Rabeneck L, Paszat LF, Saskin R,. Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastroenterol Hepatol. 2010; 8: 275-279.
29. Mysliwiec PA, Brown ML, Klabunde CN, et al. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004; 141: 264-271.
30. Boolchand V, Olds G, Singh J, et al. Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med. 2006; 145: 654-659.
31. Barclay RL, Vicari JJ, Doughty AS, et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006; 355: 2533-2541.
32. Chen SC, Rex DK,. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol. 2007; 102: 856-861.
33. Brenner H, Chang-Claude J, Seiler CM, et al. Interval cancers after negative colonoscopy: population-based case-control study [published online ahead of print December 26, 2011]. Gut. 2011.
34. Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006; 63: S16-S28.
35. Leyden JE, Doherty GA, Hanley A, et al. Quality of colonoscopy performance among gastroenterology and surgical trainees: a need for common training standards for all trainees? Endoscopy. 2011; 43: 935-940.